Biggest News Aggregation in the World
📰 Clinical Program News

Page 21 - Clinical Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinical Program. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

OSE Immunotherapeutics is Pleased to Announce that Veloxis Pharmaceuticals, Inc., its Partner in Transplantation, has Obtained FDA Fast-Track Designation for CD28 Antagonist VEL-101/FR104

Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced that Veloxis Pharmaceuticals, Inc., an Asahi Kasei company, has obtained fast track designation
France General United States Ulf Meier Kriesche Asahi Kasei Guillaume Van Renterghem Lifesci Thomas Guillot

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science